|
 |
|
EDITOR'S PAGE
Protein That Causes Blood Vessel Leakage in DR Found
By Conni Bergmann Koury, Editor-in-Chief
MACULA
Verteporfin and VEGF-Inhibitor Trial for Neovascular AMD
By Leah Farr, Associate Editor
Nonselective Followed by Selective
VEGF Blockade May Benefit AMD Patients
Reviewed By Mark S. Hughes, MD
Combined PDT With Intravitreal Bevacizumab
Useful for Neovascular AMD
By Mandeep S. Dhalla, MD, and Gaurav K. Shah, MD
DIABETES
Ranibizumab Slows Macular Vision Loss
Reviewed By Quan Dong Nguyen, MD, MSc,
and Peter A. Campochiaro, MD
Intravitreal Bevacizumab in Diabetic Macular Edema
Improved Visual Acuity, Retinal Thickness
By Christos Haritoglou, MD
Intravitreal Bevacizumab Promising for Neovasculaziation
in Diabetic Retinopathy
By Rodrigo Jorge, MD, PhD; Ingrid U. Scott, MD, MPH;
and Rogério A. Costa, MD, PhD
MEDICAL RETINA
The Importance of Vision-Related Quality of Life in Patients
Treated for Neovascular AMD
Reviewed By Tom S. Chang, MD, FRCS, MHSc
Intravitreal Injections: Technique and Infection Prophylaxis
By Miguel Busquets, MD, FACS
Retinal Pigment Epithelium Tears Linked to Bevacizumab?
By Ulrich H.M. Spandau, MD, and Jost B. Jonas, MD
COVER FOCUS
Update on Factor H and Genetic Predisposition to AMD:
How Geneticists Understand the Disease
Reviewed By Rando Allikmets, PhD
CFH, Hemicentin-1 Genes Not Associated with Dry AMD in Japanese
Reviewed By Nobuo Fuse, MD
Risk Factors and Prevention of AMD
Reviewed By Albert O. Edwards, MD, PhD
No Association of CFH Gene Polymorphism, AMD in Japanese
By Junko Uka, MD; Hiroki Tamura, MD; Takayuki Kobayashi, MD;
and Atsushi Minamoto, MD
Defining the Prevalence of AMD and Investigating Racial Differences
Reviewed By Susan B. Bressler, MD
Clinical Trial Update: AMD
Continuing Medical Education
Innovations
5 Questions: Debra A. Schaumberg, SCd, OD, ,MPH |
|
|
